Scholarly article on 5α-Cholest-8(14)-en-3α-ol 18684-35-0 from Chemistry and Physics of Lipids p. 258,262

DOI: 10.1016/0009-3084(77)90013-5

Source and publish data:

Chemistry and Physics of Lipids p. 258,262 (1977)

Update date:2022-07-29

Topics:

Authors:

Parish Parish

Schroepfer

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/0009-3084(77)90013-5

Full text of DOI:10.1016/0009-3084(77)90013-5

Products guided by the article

Product name:5α-Cholest-8(14)-en-3α-ol

Cas No:18684-35-0

R&D Labs maybe for 18684-35-0

Jinan Jiaquan Chemical Co.,Ltd

Contact:+86-531-62318366

Address:Room 502 of Yidonghuayuan No.601 Huaxin Road Licheng District Jinan China
Jinan Trio PharmaTech Co., Ltd

Contact:86-531-88811783；+(0)13153010282

Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
chengdu firsterchem Pharmaceutical Co., Ltd.

Contact:028-66825849

Address:chengdu
Disynthesis Chemical Technology Co. Ltd.

Contact:+86-571-88194596

Address:Dengyun road 380, Gongshu district, Hangzhou city, China
LINYI FUDE FINE CHEMICAL CO.,LTD

Contact:86-539-2361184

Address:YISHUI, LINYI,SAHNDONG,CHINA

Relevant to this article

Potency and inactivation rates of analogues of an irreversible inhibitor of vertebrate oxidosqualene cyclase

Doi:10.1016/S0960-894X(97)00008-5
(1997)
One-pot synthesis of some 2H-pyran-2-one derivatives

Doi:10.1002/jhet.5570330626
(1996)
Doi:10.1021/ja01077a028
(1964)
Efficient and β-stereoselective synthesis of 4(5)-methyl-5(4)-(5- amino-5-deoxy-β-D-ribofuranosyl)imidazole and related compounds exhibiting antiulcer activity

Doi:10.1248/cpb.45.53
(1997)
Doi:10.1021/ja01101a038
(1953)
Probable role of clavaminic acid as the terminal intermediate in the common pathway to clavulanic acid and the antipodal clavam metabolites

Doi:10.1021/ja963107o
(1997)

Article Doi

DOI: 10.1016/0009-3084(77)90013-5